Yazar "Bishop, N. Mogulkoc" seçeneğine göre listele
Listeleniyor 1 - 3 / 3
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Baseline Characteristics of All Patients Randomized in a Phase IIb Trial of Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis and Risk of Pulmonary Hypertension(Amer Thoracic Soc, 2019) Behr, J.; Nathan, S. D.; Harari, S.; Wuyts, W.; Bishop, N. Mogulkoc; Bouros, D. E.; Antoniou, K.; Guiot, J.; Kramer, M.; Kirchgaessler, K.; Bengus, M.; Gilberg, F.; Wells, A. U.Öğe Impact of Velcro Crackles on Progression and Survival in the European MultiPartner IPF Registry (EMPIRE)(Springer Wien, 2023) Lang, D.; Lamprecht, B.; Bishop, N. Mogulkoc; Sterclova, M.; Lewandowska, K.; Kramer, M.; Bartos, V.[No abstract available]Öğe Long-term effect of nintedanib treatment in 11 countries of Europe and Asia(European Respiratory Soc Journals Ltd, 2022) Vasakova, M. Koziar; Sterclova, M.; Bishop, N. Mogulkoc; Lewandowska, K.; Muller, V; Kramer, M.; Hajkova, M.[No abstract available]
